Synergistic silencing of a-globin and induction of ?-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for ß-thalassaemia. (2019)

First Author: Mettananda S
Attributed to:  Characterisation of ATRX, a chromatin remodelling protein funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-48204-2

PubMed Identifier: 31406232

Publication URI: http://europepmc.org/abstract/MED/31406232

Type: Journal Article/Review

Volume: 9

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322